benzoxazoles and pitavastatin
benzoxazoles has been researched along with pitavastatin in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Arai, H; Araki, E; Ishibashi, S; Suganami, H; Yamashita, S; Yokote, K | 1 |
Akazawa, K; Ito, H; Kimura, T; Kondo, M; Miura, D; Miyoshi, T; Nakamura, K; Ohno, Y; Ohtsuka, H; Yoshida, M | 1 |
Abe, H; Goto, R; Kamimura, H; Kamimura, K; Kimura, A; Morita, S; Oda, C; Ohkoshi-Yamada, M; Owaki, T; Sakai, N; Sakamaki, A; Shibata, O; Shinagawa-Kobayashi, Y; Terai, S; Yokoo, T | 1 |
Trials
1 trial(s) available for benzoxazoles and pitavastatin
Article | Year |
---|---|
Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia.
Topics: Adult; Aged; Benzoxazoles; Biomarkers; Butyrates; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Japan; Male; Middle Aged; PPAR alpha; Quinolines; Signal Transduction; Time Factors; Treatment Outcome; Triglycerides; Young Adult | 2017 |
Other Studies
2 other study(ies) available for benzoxazoles and pitavastatin
Article | Year |
---|---|
Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet.
Topics: Animals; Aorta, Thoracic; Benzoxazoles; Blood Pressure; Butyrates; Cholesterol; Cholesterol, HDL; Cholesterol, VLDL; Chylomicrons; Diet, High-Fat; Drug Therapy, Combination; Endothelium; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Insulin Resistance; Lipoproteins, HDL; PPAR alpha; Quinolines; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Triglycerides; Vasodilation | 2020 |
Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
Topics: Animal Fins; Animals; Animals, Genetically Modified; Benzhydryl Compounds; Benzoxazoles; Butyrates; Diet, High-Fat; Disease Models, Animal; Exome Sequencing; Gene Ontology; Glucosides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Non-alcoholic Fatty Liver Disease; Oryzias; PPAR alpha; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Glucose Transporter 2 Inhibitors; Transcriptome | 2022 |